Boston Bio Systems Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	-5.47	-1.41	-0.02	-0.02	-0.02	Upgrade
Other Operating Activities	0	-	-	-	-	Upgrade
Change in Accounts Payable	2.59	-	-	-	0.01	Upgrade
Change in Other Net Operating Assets	-42.96	1.41	0.01	-	-	Upgrade
Operating Cash Flow	-45.85	-	-0.01	-0.02	-0.01	Upgrade
Long-Term Debt Issued	45.75	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	45.75	-	-	-	-	Upgrade
Financing Cash Flow	45.75	-	-	-	-	Upgrade
Net Cash Flow	-0.1	-	-0.01	-0.02	-0.01	Upgrade
Free Cash Flow	-45.85	-	-0.01	-0.02	-0.01	Upgrade
Free Cash Flow Margin	-2381.61%	-	-	-	-	Upgrade
Free Cash Flow Per Share	-6.53	-	-0.00	-0.00	-0.00	Upgrade
Levered Free Cash Flow	-45.24	0.53	-0	-0	-0	Upgrade
Unlevered Free Cash Flow	-45.24	0.53	-0	-0	-0	Upgrade
Change in Net Working Capital	41.82	-1.41	-0.01	-0.01	-0.01	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.